Canada markets closed

Acasti Pharma Inc. (ACST)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.8700-0.1900 (-6.21%)
At close: 04:00PM EDT
2.9700 +0.10 (+3.48%)
After hours: 05:32PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 28.86M
Enterprise Value 3.77M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.45
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.31

Trading Information

Stock Price History

Beta (5Y Monthly) 1.52
52-Week Change 3-0.35%
S&P500 52-Week Change 320.07%
52 Week High 33.8400
52 Week Low 31.7200
50-Day Moving Average 33.2712
200-Day Moving Average 32.6063

Share Statistics

Avg Vol (3 month) 326.32k
Avg Vol (10 day) 315.55k
Shares Outstanding 59.4M
Implied Shares Outstanding 69.4M
Float 86.29M
% Held by Insiders 116.02%
% Held by Institutions 112.13%
Shares Short (Mar 28, 2024) 41.41k
Short Ratio (Mar 28, 2024) 40.04
Short % of Float (Mar 28, 2024) 40.02%
Short % of Shares Outstanding (Mar 28, 2024) 40.02%
Shares Short (prior month Feb 29, 2024) 423.16k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:6
Last Split Date 3Jul 10, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-7.92%
Return on Equity (ttm)-48.05%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -12.21M
Net Income Avi to Common (ttm)-38.77M
Diluted EPS (ttm)-5.6800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)25.11M
Total Cash Per Share (mrq)2.67
Total Debt (mrq)24k
Total Debt/Equity (mrq)0.04%
Current Ratio (mrq)15.19
Book Value Per Share (mrq)6.88

Cash Flow Statement

Operating Cash Flow (ttm)-13.57M
Levered Free Cash Flow (ttm)-7.84M